- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 103,700 | 01.10.24 17:30:30 | +0,800 | +0,78% | 0,000 | 0,000 | 103,520 | 102,900 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.046,390 | 01.10.24 21:37:16 | -4,850 | -0,46% | 1.045,340 | 1.047,130 | 1.040,730 | 1.051,240 |
